Cyclophilin A and calcineurin functions investigated by gene inactivation, cyclosporin A inhibition and cDNA arrays approaches in the phytopathogenic fungus Botrytis cinerea.

Mol Microbiol

Unité de Phytopathologie et Méthodologies de la Détection, Institut National de la Recherche Agronomique, Route de Saint-Cyr, 78086 Versailles, France.

Published: December 2003

Calcineurin phosphatase and cyclophilin A are cellular components involved in fungal morphogenesis and virulence. Their roles were investigated in the phytopathogenic fungus Botrytis cinerea using gene inactivation, drug inhibition and cDNA macroarrays approaches. First, the BCP1 gene coding for cyclophilin A was identified and inactivated by homologous recombination. The bcp1Delta null mutant obtained was still able to develop infection structures but was altered in symptom development on bean and tomato leaves. Opposite to this, calcineurin inhibition using cyclosporin A (CsA) modified hyphal morphology and prevented infection structure formation. CsA drug pattern signature on macroarrays allowed the identification of 18 calcineurin-dependent (CND) genes among 2839 B. cinerea genes. Among the co-regulated CND genes, three were shown to be organized as a physical cluster that could be involved in secondary metabolism. The signature of BCP1 inactivation on macroarrays allowed the identification of only three BCP1 cyclophilin-dependent (CPD) genes that were different from CND genes. Finally, no CsA drug pattern signature was observed in the bcp1Delta null mutant which provided a molecular target validation of the drug.

Download full-text PDF

Source
http://dx.doi.org/10.1046/j.1365-2958.2003.03798.xDOI Listing

Publication Analysis

Top Keywords

cnd genes
12
gene inactivation
8
inhibition cdna
8
phytopathogenic fungus
8
fungus botrytis
8
botrytis cinerea
8
bcp1delta null
8
null mutant
8
csa drug
8
drug pattern
8

Similar Publications

Hematologic Cancer after Gene Therapy for Cerebral Adrenoleukodystrophy.

N Engl J Med

October 2024

From Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School (C.N.D., D.A.W.), the Department of Pathology, Boston Children's Hospital (J.R.B., M.H.H.), and Massachusetts General Hospital and Harvard Medical School (F.S.E.) - all in Boston; the Department of Laboratory Medicine and Pathology, University of Minnesota Medical Center (B.G., A.B.), and the Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota (A.O.G., P.J.O.) - both in Minneapolis; Bluebird Bio, Somerville, MA (M.B., S.S., R.A.C., V.K.P., G.F.D., F.J.P., M.A.K., M.F., A.L., N.F., G.P., A.C.D., H.L.T.); the Department of Pediatric Oncology, Hematology and Hemostaseology, Leipzig University Hospital, Leipzig, Germany (J.-S.K.); and the Division of Pediatric Transplant and Cellular Therapy, Duke University School of Medicine, Durham, NC (V.K.P.).

Article Synopsis
  • Gene therapy using elivaldogene autotemcel (eli-cel) has shown effectiveness in treating cerebral adrenoleukodystrophy but raises concerns about cancer risks.
  • Research analyzed blood and bone marrow samples from patients who received eli-cel to evaluate integration sites and other genetic factors.
  • Out of 67 patients treated, 7 developed hematologic cancers, with multiple instances linked to lentiviral vector insertions, though some patients successfully underwent stem cell transplantation and remained symptom-free.
View Article and Find Full Text PDF

The interaction between menin and histone-lysine N-methyltransferase 2A (KMT2A) is a critical dependency for KMT2A- or nucleophosmin 1 (NPM1)-altered leukemias and an emerging opportunity for therapeutic development. JNJ-75276617 (bleximenib) is a novel, orally bioavailable, potent, and selective protein-protein interaction inhibitor of the binding between menin and KMT2A. In KMT2A-rearranged (KMT2A-r) and NPM1-mutant (NPM1c) acute myeloid leukemia (AML) cells, JNJ-75276617 inhibited the association of the menin-KMT2A complex with chromatin at target gene promoters, resulting in reduced expression of several menin-KMT2A target genes, including MEIS1 and FLT3.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated how different Pakistani dietary fats affect metabolic and cardiovascular health by observing the effects on four groups of mice over 16 weeks.
  • Mice on high-fat diets (HFD) gained more weight, with blood tests showing increased glucose and cholesterol levels, particularly in those consuming banaspati ghee (HFD-BG).
  • Histological analysis revealed that mice on HFD-BG and plant oil (HFD-O) had more lipid accumulation in their livers than those on desi ghee (HFD-DG) and the control group (C-ND).
View Article and Find Full Text PDF

Candidate targets of copy number deletion events across 17 cancer types.

Front Genet

January 2023

Department of Molecular Life Science, University of Zurich, Zurich, Switzerland.

Genome variation is the direct cause of cancer and driver of its clonal evolution. While the impact of many point mutations can be evaluated through their modification of individual genomic elements, even a single copy number aberration (CNA) may encompass hundreds of genes and therefore pose challenges to untangle potentially complex functional effects. However, consistent, recurring and disease-specific patterns in the genome-wide CNA landscape imply that particular CNA may promote cancer-type-specific characteristics.

View Article and Find Full Text PDF

Comprehensive Etiologic Analyses in Pediatric Cochlear Implantees and the Clinical Implications.

Biomedicines

July 2022

Department of Otolaryngology-Head and Neck Surgery, Taichung Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taichung 42743, Taiwan.

Cochlear implantation is the treatment of choice for children with profound sensorineural hearing impairment (SNHI), yet the outcomes of cochlear implants (CI) vary significantly across individuals. To investigate the CI outcomes in pediatric patients with SNHI due to various etiologies, we prospectively recruited children who underwent CI surgery at two tertiary referral CI centers from 2010 to 2021. All patients underwent comprehensive history taking, next generation sequencing (NGS)-based genetic examinations, and imaging studies.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!